BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8443002)

  • 1. Effects of two new vitamin D3 derivatives, 22-oxa-1 alpha-25-dihydroxyvitamin D3 (OCT) and 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture.
    Sato K; Nishii Y; Woodiel FN; Raisz LG
    Bone; 1993; 14(1):47-51. PubMed ID: 8443002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
    Harada M; Miyahara T; Miyata M; Tomita I; Okayachi H; Ikemoto Y; Higuchi S; Otomo S; Kozuka H; Ikekawa N
    Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo.
    Miyahara T; Harada M; Kozakai A; Matsumoto M; Hashimoto K; Inoue H; Yoda K; Nakatsu T; Kajita S; Yamazaki R; Higuchi S; Kozuka H; Nemoto N
    J Nutr Sci Vitaminol (Tokyo); 1999 Jun; 45(3):239-49. PubMed ID: 10524344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of vitamin D metabolites on collagen synthesis and resportion of fetal rat bone in organ culture.
    Raisz LG; Kream BE; Smith MD; Simmons HA
    Calcif Tissue Int; 1980; 32(2):135-8. PubMed ID: 6773630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in metabolism between 26,26,26,27,27,27-hexafluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in cultured neonatal mouse calvaria.
    Harada M; Miyahara T; Kajita-Kondo S; Kozakai A; Higuchi S; Otomo S; Kozuka H
    Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):183-93. PubMed ID: 7881867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium regulating activity of 24a-homo-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-dimethyl-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3.
    Harada M; Miyahara T; Miyata M; Komiyama H; Sugure A; Ikemoto Y; Kondo S; Takamura T; Higuchi S; Otomo S
    Calcif Tissue Int; 1993 Nov; 53(5):318-23. PubMed ID: 8287319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related effects of 1,25-dihydroxyvitamin D3 on growth, modeling, and morphology of fetal mouse metatarsals cultured in serum-free medium.
    Bagi CM; Miller SC
    J Bone Miner Res; 1992 Jan; 7(1):29-40. PubMed ID: 1549956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unique action for bone metabolism of 1 alpha,25-(OH)2D3-26,23-lactone.
    Kiyoki M; Kurihara N; Ishizuka S; Ishii S; Hakeda Y; Kumegawa M; Norman AW
    Biochem Biophys Res Commun; 1985 Mar; 127(2):693-8. PubMed ID: 3838477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogens inhibit in vitro bone resorption stimulated by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogs EB1089 and KH1060.
    Vink-van Wijngaarden T; Birkenhäger JC; Kleinekoort WM; van den Bemd GJ; Pols HA; van Leeuwen JP
    Endocrinology; 1995 Feb; 136(2):812-5. PubMed ID: 7835315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of Vitamin D analogs on bone formation and resorption.
    Nakane M; Fey TA; Dixon DB; Ma J; Brune ME; Li YC; Wu-Wong JR
    J Steroid Biochem Mol Biol; 2006 Jan; 98(1):72-7. PubMed ID: 16242929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory activities of 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism.
    Okano T; Tsugawa N; Masuda S; Takeuchi A; Kobayashi T; Takita Y; Nishii Y
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1444-9. PubMed ID: 2551289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-Dihydroxyvitamin D3 effects on collagen and DNA synthesis in periosteum and periosteum-free calvaria.
    Canalis E; Lian JB
    Bone; 1985; 6(6):457-60. PubMed ID: 3841646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.
    Cross HS; Farsoudi KH; Peterlik M
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):105-10. PubMed ID: 8446178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D3 and 22-oxa-1,25-dihydroxyvitamin D3 in vivo nuclear receptor binding in developing bone during endochondral and intramembranous ossification.
    Stumpf WE; Koike N; Hayakawa N; Tokuda K; Nishimiya K; Tsuchiya Y; Hirate J; Okazaki A; Kumaki K
    Histochemistry; 1994 Sep; 102(3):183-94. PubMed ID: 7868361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avian medullary bone in organ culture: effects of vitamin D metabolites on collagen synthesis.
    Harrison JR; Clark NB
    Calcif Tissue Int; 1986 Jul; 39(1):35-43. PubMed ID: 3015364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium regulating activity of 26,27-dialkyl analogs of 1 alpha,25-dihydroxyvitamin D3.
    Miyahara T; Harada M; Miyata M; Sugure A; Ikemoto Y; Takamura T; Higuchi S; Otomo S; Kozuka H; Ikekawa N
    Calcif Tissue Int; 1992 Sep; 51(3):218-22. PubMed ID: 1330237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites in vivo and in vitro.
    Ishizuka S; Sumitani K; Hiura K; Kawata T; Okawa M; Hakeda Y; Kumegawa M
    Endocrinology; 1990 Aug; 127(2):695-701. PubMed ID: 2373050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro.
    Hara K; Akiyama Y; Tajima T; Shiraki M
    J Bone Miner Res; 1993 May; 8(5):535-42. PubMed ID: 8511981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.